Inke S.A: APIs manufacturing plant.

Reset all filters
01 1INKE, S.A.
02 1Neuland Laboratories Limited
03 1Teva API India Private Ltd
04 3Apotex Inc.
05 2Aurobindo Pharma Limited
06 1Cadila Pharmaceuticals Limited
07 1Cambrex Karlskoga AB
08 1Chromo Laboratories India Private Limited
09 1Eli Lilly Kinsale Limited
10 1Hetero Drugs Limited
11 2Jubilant Biosys limited
12 1SUN PHARMACEUTICAL INDUSTRIES, INC.
13 1Solara Active Pharma Sciences Limited
14 1YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
15 1Zhejiang Supor Pharmaceuticals Co., Ltd
Reset all filters
01 4OLANZAPINE
02 12Olanzapine
03 1Olanzapine (Form-II)
04 1Olanzapine Form-1)
05 1Olanzapine Form-I
Reset all filters
01 3Canada
02 2China
03 10India
04 1Israel
05 1Spain
06 2U.S.A
NDC Package Code : 64567-0017
Start Marketing Date : 2013-01-24
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-0122
Start Marketing Date : 2017-12-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 15894-0006
Start Marketing Date : 2019-07-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49867-0056
Start Marketing Date : 2010-11-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 49867-0073
Start Marketing Date : 2022-07-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 49867-0078
Start Marketing Date : 2008-09-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 12651-125
Start Marketing Date : 2023-10-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 52562-013
Start Marketing Date : 2020-03-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 49587-103
Start Marketing Date : 2014-12-22
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14799-2010
Start Marketing Date : 2010-08-16
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

53
PharmaCompass offers a list of Olanzapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Olanzapine manufacturer or Olanzapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olanzapine manufacturer or Olanzapine supplier.
A ZYPREXA RELPREVV manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ZYPREXA RELPREVV, including repackagers and relabelers. The FDA regulates ZYPREXA RELPREVV manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ZYPREXA RELPREVV API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ZYPREXA RELPREVV manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A ZYPREXA RELPREVV supplier is an individual or a company that provides ZYPREXA RELPREVV active pharmaceutical ingredient (API) or ZYPREXA RELPREVV finished formulations upon request. The ZYPREXA RELPREVV suppliers may include ZYPREXA RELPREVV API manufacturers, exporters, distributors and traders.
click here to find a list of ZYPREXA RELPREVV suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ZYPREXA RELPREVV as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ZYPREXA RELPREVV API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ZYPREXA RELPREVV as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ZYPREXA RELPREVV and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ZYPREXA RELPREVV NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ZYPREXA RELPREVV suppliers with NDC on PharmaCompass.
We have 15 companies offering ZYPREXA RELPREVV
Get in contact with the supplier of your choice: